Paid Clinical Trials in Riverside, CA
As of September 2026, 91 paid clinical trials are recruiting in Riverside, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Riverside offers studies at sites including Kaiser Permanente-Riverside for conditions such as Schizophrenia, Bipolar Disorder, Bipolar I Disorder, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Riverside
Trials by drug in Riverside
Filter results
Newly added in Riverside
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
85 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Brenipatide in Participants With Alcohol Use Disorder
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ALTO-100 in Bipolar Disorder With Depression (BD-D)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Pivotal Study of the Velocity™ pAVF System
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
WRAP North America
Top Research Study Locations in Riverside
Researchers run research studies in Riverside, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Kaiser Permanente-Riverside | Breast Cancer, Chronic Lymphocytic Leukemia, Ovarian Carcinoma | 19 |
| Artemis Institute for Clinical Research | Overweight, Chronic Pain, Obesity | 12 |
| Kaiser Permanente Riverside Medical Center | Age-Related Macular Degeneration, Intracerebral Hemorrhage, Pneumonia | 6 |
| Clinical Innovations, Inc. dba CITrials | Bipolar Disorder, Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features | 4 |
| Riverside Clinical | Alzheimers Disease, Obesity, Abdominal, Overweight | 3 |
| Apex Research | Arteriovenous Fistula, Chronic Kidney Disease, Dialysis; Complications | 2 |
| Neurocrine Clinical Site | Schizophrenia | 2 |
| University of California, Riverside | Cognitive Change, Hearing Handicap | 2 |
| CenExel | Bipolar I Disorder, Depressive Disorder, Major | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Apex Research of Riverside | Venous Occlusion, Venous Stenosis | 1 |
| Artemis Institute for Clinical Research - Riverside | Diabetic Peripheral Neuropathic Pain | 1 |
| CARI Clinical Trials | Venous Thromboembolism (VTE) | 1 |
| CARI Clinical Trials INC | Ventral Hernia | 1 |
| CenExel CIT IE | Schizophrenia Disorders | 1 |
| Clinical Innovations Inc | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 1 |
| Clinical Innovations, Inc | Bipolar Depression, Bipolar Disorder, Bipolar I Disorder | 1 |
| Clinical Innovations, Inc. | Schizophrenia | 1 |
| GSK Investigational Site | Influenza, Human | 1 |
| Glenwood Surge Ctr | Lumbar Spinal Stenosis | 1 |
| HCA Riverside Community Hospital | Interstitial Lung Disease (ILD), Pulmonary Hypertension | 1 |
| Kaiser Permanente - Riverside Medical Center | Neovascular Age-related Macular Degeneration | 1 |
| Kaiser Permanente Southern California | Prostatic Neoplasms, Castration-Resistant | 1 |
| Kaiser Permanente-Riverside Medical Center | Uveal Melanoma | 1 |
| Kindful Restoration | HIV Prevention, Hepatitis C Virus (HCV), Incarceration | 1 |
Active & Upcoming Studies in Riverside (2026)
Recruiting trials in Riverside grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (24 active studies)
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
- Neoadjuvant Darovasertib in Primary Uveal Melanoma · Phase 3 · IDEAYA Biosciences
Mental health & behavior (17 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications · Phase 3 · Minerva Neurosciences
Neurology & pain (11 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (4 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION) · Phase 3 · Amgen
Eye & vision (3 active studies)
- Phase 2 Study of ADX-038 in Participants With Geographic Atrophy · Phase 2 · ADARx Pharmaceuticals, Inc.
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
Cardiovascular (2 active studies)
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension · Tempus AI
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
HIV / STI (1 active study)
- California MEPS Hub · University of California, Los Angeles
Pediatric (1 active study)
- Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy · Loma Linda University
Common conditions studied in Riverside
- Schizophrenia (6 active studies)
- Bipolar Disorder (3 active studies)
- Bipolar I Disorder (3 active studies)
- Breast Cancer (3 active studies)
- Overweight (3 active studies)
- Alcohol Use Disorder (2 active studies)
Leading research sponsors in Riverside
- Eli Lilly and Company
- NRG Oncology
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Riverside?
There are approximately 91 recruiting clinical trials in Riverside, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Riverside pay participants?
Most recruiting trials in Riverside compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Riverside?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Riverside?
The most common conditions under active study in Riverside include Schizophrenia (6), Bipolar Disorder (3), Bipolar I Disorder (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Riverside?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Riverside on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Riverside?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Riverside?
Recruiting research sites in Riverside include Kaiser Permanente-Riverside, Artemis Institute for Clinical Research, Kaiser Permanente Riverside Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Riverside right now?
The largest active categories in Riverside are Cancer & tumors (24), Mental health & behavior (17), Neurology & pain (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.